Necroptosis: a crucial pathogenic mediator of human disease

Area of Science:

• Biochemistry
• Molecular Biology
• Pathology

Background:

• Necroptosis is a regulated necrotic cell death pathway implicated in human diseases.
• The pathway involves receptor-interacting protein kinases 1 and 3 (RIPK1 and RIPK3) and mixed-lineage kinase domain-like pseudokinase (MLKL).
• RIPK3-mediated phosphorylation of MLKL triggers necroptosis.

Purpose of the Study:

• To review the roles of RIPK3 and MLKL in disease pathogenesis.
• To explore their function as determinants and markers of disease severity.
• To cover their involvement in diverse experimental models of human diseases.

Main Methods:

• Literature review of experimental studies.
• Analysis of animal models of tissue injury.
• Focus on the molecular mechanisms of necroptosis.

Main Results:

• RIPK3 and MLKL are key effectors in injury propagation.
• These proteins are crucial pathogenic determinants across multiple disease models.
• Their activity correlates with disease progression and severity.

Conclusions:

• RIPK3 and MLKL are vital in necroptosis.
• These molecules serve as important indicators of disease.
• Targeting necroptosis pathways may offer therapeutic strategies.